HANEY CECIL D sold $361K of THC

HANEY CECIL D sold 1,300 shares of TENET HEALTHCARE CORP (THC) at $278.03 ($0.36M total) on 2026-08-24.

Original reporting
SEC EDGAR · HANEY CECIL D
Published Aug 27, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 12:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

A director's sale of 1,300 shares for $361k is disclosed for the first time, providing new data for traders monitoring insider activity.

02

Market read

First‑report insider sale; modest size but may influence short‑term sentiment.

03

What to watch

No accompanying corporate news; the director retains a sizable stake.

Relevance 4/10Novelty 4/10Timing: post‑market filing on Aug 26

Background

SEC Form 4 filing discloses insider transactions. Tenet Healthcare (THC) is a NYSE‑listed healthcare services company.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

Director Haney Cecil D sold 1,300 shares of Tenet Healthcare for $361,439.

Expected impact

Modest short-term downside pressure

Evidence & confidence

Director sales are closely watched; a $361k sale is modest but could trigger sell‑offs among short‑term traders.

Market effects

Minimal impact on healthcare sector; typical insider transaction.

None

Low

Counterpoint

The sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Tenet Healthcare Corp

    NYSE‑listed healthcare services provider.

  • Haney Cecil D

    Director of Tenet Healthcare who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.